Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the absolute bioavailability and pharmacokinetics of
vedolizumab following a single injection of vedolizumab subcutaneously at 3 varying doses.